Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory.

Andreas Lind, Regine Barlinn, Elisabeth Toverud Landaas, Lise Lima Andresen, Kirsti Jakobsen, Cathrine Fladeby, Mariann Nilsen, P��l Marius Bj��rnstad, Arvind Y M Sundaram, Teodora Ribarska, Fredrik M��ller, Gregor D Gilfillan, Mona Holberg-Petersen
Author Information
  1. Andreas Lind: Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  2. Regine Barlinn: Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  3. Elisabeth Toverud Landaas: Department of Microbiology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  4. Lise Lima Andresen: Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  5. Kirsti Jakobsen: Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  6. Cathrine Fladeby: Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  7. Mariann Nilsen: Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  8. P��l Marius Bj��rnstad: Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  9. Arvind Y M Sundaram: Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  10. Teodora Ribarska: Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  11. Fredrik M��ller: Department of Microbiology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  12. Gregor D Gilfillan: Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  13. Mona Holberg-Petersen: Department of Microbiology, Oslo University Hospital, Oslo, Norway.

Abstract

OBJECTIVES: The emerging SARS-CoV-2 variants of concern (VoC), B.1.1.7, B.1.351 and P.1, with increased transmission and/or immune evasion, emphasise the need for broad and rapid variant monitoring. Our high-volume laboratory introduced a PCR variant assay (Variant PCR) in January 2021 based on the protocol by Vogels et al. STUDY DESIGN: To assess whether Variant PCR could be used for rapid B.1.1.7, B.1.351 and P.1 screening, all positive SARS-CoV-2 airway samples were prospectively tested in parallel using both the Variant PCR and whole genome sequencing (WGS).
RESULTS: In total 1,642 SARS-CoV-2 positive samples from individual patients were tested within a time span of 4 weeks. For all samples with valid results from both Variant PCR and WGS, no VoC was missed by Variant PCR (totalling 399 VoC detected). Conversely, all of the samples identified as "other lineages" (i.e., "non-VoC lineages") by the Variant PCR, were confirmed by WGS.
CONCLUSIONS: The Variant PCR based on the protocol by Vogels et al., is an effective method for rapid screening for VoC, applicable for most diagnostic laboratories within a pandemic setting. WGS is still required to confirm the identity of certain variants and for continuous surveillance of emerging VoC.

Keywords

References

  1. Euro Surveill. 2020 Jan;25(3): [PMID: 31992387]
  2. J Clin Microbiol. 2005 Sep;43(9):4551-7 [PMID: 16145106]
  3. Nat Microbiol. 2020 Oct;5(10):1299-1305 [PMID: 32651556]
  4. Cell. 2021 Mar 4;184(5):1171-1187.e20 [PMID: 33621484]
  5. Nat Methods. 2012 Mar 04;9(4):357-9 [PMID: 22388286]
  6. J Clin Microbiol. 1990 Mar;28(3):495-503 [PMID: 1691208]
  7. Euro Surveill. 2021 Jan;26(1): [PMID: 33413740]
  8. BMC Bioinformatics. 2019 May 10;20(1):236 [PMID: 31077131]
  9. Genome Biol. 2019 Jan 8;20(1):8 [PMID: 30621750]
  10. BMC Bioinformatics. 2019 Dec 27;20(Suppl 23):606 [PMID: 31881822]
  11. Nat Microbiol. 2020 Nov;5(11):1403-1407 [PMID: 32669681]
  12. Cureus. 2021 Mar 11;13(3):e13819 [PMID: 33728228]
  13. Nat Med. 2020 Sep;26(9):1405-1410 [PMID: 32678356]
  14. Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4 [PMID: 33535027]
  15. Science. 2021 Apr 9;372(6538): [PMID: 33658326]
  16. Bioinformatics. 2018 Dec 1;34(23):4121-4123 [PMID: 29790939]
  17. N Engl J Med. 2019 Dec 26;381(26):2569-2580 [PMID: 31881145]
  18. Lancet. 2021 Feb 6;397(10273):452-455 [PMID: 33515491]

MeSH Term

COVID-19
Humans
Laboratories
Polymerase Chain Reaction
SARS-CoV-2
Whole Genome Sequencing

Word Cloud

Created with Highcharts 10.0.01PCRVariantBSARS-CoV-2VoCWGSsamples7351Prapidvariantscreeningemergingvariantsmonitoringhigh-volumelaboratorybasedprotocolVogelsetalpositivetestedusingwholegenomesequencingwithinlineages"confirmeddiagnosticOBJECTIVES:concernincreasedtransmissionand/orimmuneevasionemphasiseneedbroadintroducedassayJanuary2021STUDYDESIGN:assesswhetherusedairwayprospectivelyparallelRESULTS:total642individualpatientstimespan4weeksvalidresultsmissedtotalling399detectedConverselyidentified"otherie"non-VoCCONCLUSIONS:effectivemethodapplicablelaboratoriespandemicsettingstillrequiredconfirmidentitycertaincontinuoussurveillanceRapidVariantsWholeGenomeSequencing

Similar Articles

Cited By